KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Total Liabilities: 2009-2025

Historic Total Liabilities for Thermo Fisher Scientific (TMO) over the last 16 years, with Sep 2025 value amounting to $52.0 billion.

  • Thermo Fisher Scientific's Total Liabilities rose 1.18% to $52.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $52.0 billion, marking a year-over-year increase of 1.18%. This contributed to the annual value of $47.7 billion for FY2024, which is 8.18% down from last year.
  • Thermo Fisher Scientific's Total Liabilities amounted to $52.0 billion in Q3 2025, which was up 2.52% from $50.7 billion recorded in Q2 2025.
  • In the past 5 years, Thermo Fisher Scientific's Total Liabilities registered a high of $54.3 billion during Q4 2021, and its lowest value of $30.8 billion during Q3 2021.
  • Over the past 3 years, Thermo Fisher Scientific's median Total Liabilities value was $51.4 billion (recorded in 2024), while the average stood at $51.0 billion.
  • Its Total Liabilities has fluctuated over the past 5 years, first soared by 67.55% in 2022, then decreased by 8.18% in 2024.
  • Thermo Fisher Scientific's Total Liabilities (Quarterly) stood at $54.3 billion in 2021, then dropped by 2.11% to $53.1 billion in 2022, then decreased by 2.13% to $52.0 billion in 2023, then fell by 8.18% to $47.7 billion in 2024, then increased by 1.18% to $52.0 billion in 2025.
  • Its Total Liabilities was $52.0 billion in Q3 2025, compared to $50.7 billion in Q2 2025 and $49.7 billion in Q1 2025.